ACRE’s 12% Yield Looks Risky Against Unsustainable Payout
Forward-Looking Analysis
Consensus analyst ratings for Ares Commercial Real EstateACRE-- currently stand at "Reduce," with an average rating score of 1.67 derived from one buy, two hold, and three sell ratings. The consensus price target is set at $5.38, implying approximately 11.6% upside potential from the current trading price of $4.82. Analyst coverage has remained active, with five research reports published in the past 90 days, indicating sustained institutional interest. Looking ahead, earnings are projected to grow by 35.00% over the next year, with estimates rising from $0.40 to $0.54 per share. However, the company currently trades at a negative Price-to-Earnings ratio of -13.37, reflecting its recent history of negative earnings which prevents direct comparison with profitable peers. The stock is rated 2.5 out of 5 for earnings and valuation. While the Price-to-Book ratio of 0.52 suggests the company may be undervalued relative to its assets, the negative earnings multiple remains a significant headwind. The dividend strength is rated weak at 1.7 out of 5, with a projected payout ratio of 111.11% based on EPS estimates, raising concerns about the sustainability of the current 12.02% yield. Short interest is considered healthy at 3.55% of the float, with a days-to-cover ratio of 4.28, and recent data shows a slight decrease in short positions by 0.15%, suggesting marginal improvement in investor sentiment.
Ares Commercial Real Estate reported a net loss of $9.61 million for the first quarter of 2026. The company recorded an EPS of -$0.15 for the period, reflecting continued profitability challenges. Gross profit data was not available for this specific quarter. These figures highlight the persistent headwinds faced by the mortgage REIT in maintaining consistent earnings generation amidst fluctuating market conditions.

Additional News
Recent market data indicates Ares Commercial Real Estate is trading at $4.97, reflecting a daily change of (1.2%). The stock has a beta of 1.04 and a market capitalization of $270 million. The company operates in the Financials sector, specifically within Mortgage Real Estate Investment Trusts. Historical performance shows ACREACRE-- has returned 2.59% over the past year, significantly underperforming the S&P 500, which returned 19.32% over the same period. Over five years, ACRE has seen an annualized return of -5.2%, compared to the S&P 500's 12.91%. The company offers a high dividend yield of 12.22%, placing it in the top 25% of dividend-paying stocks, although dividend growth lacks a long track record. News sentiment for ACRE is currently positive at 0.86, higher than the finance sector average of 0.72. Institutional ownership stands at 41.34%, indicating strong market trust, while insider ownership is low at 2.30%. No insider buying or selling has occurred in the past three months. The company continues to engage in originating and investing in commercial real estate loans and related investments, founded in September 2011 and headquartered in New York, NY.
Summary & Outlook
Ares Commercial Real Estate faces significant financial headwinds, evidenced by recent negative EPS and net losses. While the stock trades at a discount to book value, the unsustainable dividend payout ratio and negative earnings multiple present substantial risks. The projected 35% earnings growth offers a potential catalyst, but the current "Reduce" consensus and underperformance against the broader market suggest caution. The high dividend yield may attract income seekers, but the lack of earnings stability and weak dividend growth prospects temper optimism. Overall, the outlook remains neutral to bearish due to persistent profitability issues and the challenging macroeconomic environment for commercial real estate lending. Investors should monitor upcoming earnings for signs of improved net income and dividend sustainability before considering entry.
Get noticed about the list of notable companies` earning reports after markets close today and before markets open tomorrow.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.



Comments
No comments yet